⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1100191 | 0.86 | LMNA (0.35) | — | |
| SCHEMBL1257638 | 0.68 | ALDH1A1 (0.40) | — | |
| SCHEMBL3107986 | 0.65 | — | — | |
| SCHEMBL3974150 | 0.58 | RAB9A (0.53) | — | |
| SCHEMBL21040186 | 0.55 | MAPT (0.33) | — | |
| SCHEMBL11582923 | 0.55 | HSD17B10 (0.53) | — | |
| SCHEMBL4273317 | 0.55 | CCNA2 (0.36) | — | |
| SCHEMBL632364 | 0.55 | PDE10A (0.39) | — | |
| SCHEMBL8548875 | 0.55 | — | — | |
| SCHEMBL5699880 | 0.54 | HPGD (0.65) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8637562-B2 | Methods for detecting sulfhydryl-containing compounds in a biological test sample | THERAVANCE, INC. (US) | 2014-01-28 | — | — | US | disclosed |
| US-8637562-B2 | Methods for detecting sulfhydryl-containing compounds in a biological test sample | THERAVANCE, INC. (US) | 2014-01-28 | — | — | US | disclosed |
| US-8637562-B2 | Methods for detecting sulfhydryl-containing compounds in a biological test sample | THERAVANCE, INC. (US) | 2014-01-28 | — | — | US | disclosed |
| US-20130109046-A1 | METHODS FOR DETECTING SULFHYDRYL-CONTAINING COMPOUNDS IN A BIOLOGICAL TEST SAMPLE | THERAVANCE, INC. (US) | 2013-05-02 | — | — | US | disclosed |
| US-20130109046-A1 | METHODS FOR DETECTING SULFHYDRYL-CONTAINING COMPOUNDS IN A BIOLOGICAL TEST SAMPLE | THERAVANCE, INC. (US) | 2013-05-02 | — | — | US | disclosed |
| US-20130109046-A1 | METHODS FOR DETECTING SULFHYDRYL-CONTAINING COMPOUNDS IN A BIOLOGICAL TEST SAMPLE | THERAVANCE, INC. (US) | 2013-05-02 | — | — | US | disclosed |
| US-8362061-B2 | Methods for detecting sulfhydryl-containing compounds in a biological test sample | THERAVANCE, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-8362061-B2 | Methods for detecting sulfhydryl-containing compounds in a biological test sample | THERAVANCE, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-8362061-B2 | Methods for detecting sulfhydryl-containing compounds in a biological test sample | THERAVANCE, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-20120264223-A1 | METHODS FOR DETECTING SULFHYDRYL-CONTAINING COMPOUNDS IN A BIOLOGICAL TEST SAMPLE | THERAVANCE, INC. (US) | 2012-10-18 | — | — | US | disclosed |
| US-20120264223-A1 | METHODS FOR DETECTING SULFHYDRYL-CONTAINING COMPOUNDS IN A BIOLOGICAL TEST SAMPLE | THERAVANCE, INC. (US) | 2012-10-18 | — | — | US | disclosed |
| US-20120264223-A1 | METHODS FOR DETECTING SULFHYDRYL-CONTAINING COMPOUNDS IN A BIOLOGICAL TEST SAMPLE | THERAVANCE, INC. (US) | 2012-10-18 | — | — | US | disclosed |
| US-8232306-B2 | Methods for detecting sulfhydryl-containing compounds in a biological test sample | THERAVANCE, INC. (US) | 2012-07-31 | — | — | US | disclosed |
| US-8232306-B2 | Methods for detecting sulfhydryl-containing compounds in a biological test sample | THERAVANCE, INC. (US) | 2012-07-31 | — | — | US | disclosed |
| US-8232306-B2 | Methods for detecting sulfhydryl-containing compounds in a biological test sample | THERAVANCE, INC. (US) | 2012-07-31 | — | — | US | disclosed |
| US-20100099134-A1 | METHODS FOR DETECTING SULFHYDRYL-CONTAINING COMPOUNDS IN A BIOLOGICAL TEST SAMPLE | THERAVANCE BIOPHARMA R&D IP, LLC | 2010-04-22 | — | — | US | disclosed |
| WO-2010045420-A1 | METHODS FOR DETECTING SULFHYDRYL-CONTAINING COMPOUNDS IN A BIOLOGICAL TEST SAMPLE | THERAVANCE, INC. (US) | 2010-04-22 | — | — | WO | disclosed |
| US-20100099134-A1 | METHODS FOR DETECTING SULFHYDRYL-CONTAINING COMPOUNDS IN A BIOLOGICAL TEST SAMPLE | THERAVANCE BIOPHARMA R&D IP, LLC | 2010-04-22 | — | — | US | disclosed |
| WO-2010045420-A1 | METHODS FOR DETECTING SULFHYDRYL-CONTAINING COMPOUNDS IN A BIOLOGICAL TEST SAMPLE | THERAVANCE, INC. (US) | 2010-04-22 | — | — | WO | disclosed |
| US-20100099134-A1 | METHODS FOR DETECTING SULFHYDRYL-CONTAINING COMPOUNDS IN A BIOLOGICAL TEST SAMPLE | THERAVANCE BIOPHARMA R&D IP, LLC | 2010-04-22 | — | — | US | disclosed |